The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, FSD Pharma Inc (NASDAQ: HUGE) closed at $0.37 up 0.62% from its previous closing price of $0.37. In other words, the price has increased by $0.62 from its previous closing price. On the day, 1.2 million shares were traded. HUGE stock price reached its highest trading level at $0.3799 during the session, while it also had its lowest trading level at $0.35.
Ratios:
For a deeper understanding of FSD Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.43 and its Current Ratio is at 2.43. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUGE now has a Market Capitalization of 15381936 and an Enterprise Value of 11341665.
Stock Price History:
The Beta on a monthly basis for HUGE is 0.65, which has changed by -0.6983607 over the last 52 weeks, in comparison to a change of 0.22379243 over the same period for the S&P500. Over the past 52 weeks, HUGE has reached a high of $1.68, while it has fallen to a 52-week low of $0.35. The 50-Day Moving Average of the stock is -44.82%, while the 200-Day Moving Average is calculated to be -62.73%.
Shares Statistics:
For the past three months, HUGE has traded an average of 210.32K shares per day and 472510 over the past ten days. A total of 39.38M shares are outstanding, with a floating share count of 33.57M. Insiders hold about 16.97% of the company’s shares, while institutions hold 1.21% stake in the company. Shares short for HUGE as of 1713139200 were 373988 with a Short Ratio of 1.78, compared to 1710460800 on 436573. Therefore, it implies a Short% of Shares Outstanding of 373988 and a Short% of Float of 1.08.
Earnings Estimates
On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.03. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $710k. There is a high estimate of $710k for the next quarter, whereas the lowest estimate is $710k.
Based on 1 analysts’ estimates, the company’s revenue will be $8.68M in the next fiscal year. The high estimate is $8.68M and the low estimate is $8.68M.
